MRX 📈 Marex Group Ordinary Shares - Overview
Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock •
MRX: Financial Derivatives, Commodities, Metals, Agricultural Products, Securities
Marex Group plc, a financial services platform, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets. It operates through four segments: Market Making, Clearing, Agency and Execution, and Hedging and Investment Solutions. The company offers execution and clearing services in metals, agricultural products, and financial futures and options; liquidity and execution services for financial securities through trading desks that cover products, including foreign exchange, equities, fixed income, and others. It also acts as an agent to trades in OTC energy products using knowledge of the energy sector and relationships with clients; and provides market making services across commodities markets, such as metals, agricultural products, and energy and securities markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across commodity markets comprising agriculture, metals, energy, and currency markets. Further, it engages in the structured notes business, which allows investors to build their own structured notes across asset classes, including commodities, equities, foreign exchange, and fixed income products for private banks, independent asset managers, pension funds, and corporates. The company operates in the United Kingdom, the United States, and internationally. Marex Group plc was incorporated in 2005 and is headquartered in London, the United Kingdom. Web URL: https://www.marex.com
Additional Sources for MRX Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MRX Stock Overview
Market Cap in USD | 1,785m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2024-04-25 |
MRX Stock Ratings
Growth 5y | 73.2% |
Fundamental | 13.9% |
Dividend | 20.2% |
Rel. Strength Industry | 221 |
Analysts | 4.5/5 |
Fair Price Momentum | 31.08 USD |
Fair Price DCF | 100.93 USD |
MRX Dividends
Dividend Yield 12m | 0.93% |
Yield on Cost 5y | 1.49% |
Annual Growth 5y | 0.00% |
Payout Consistency | 100.0% |
MRX Growth Ratios
Growth Correlation 3m | 95% |
Growth Correlation 12m | 93.7% |
Growth Correlation 5y | 93.7% |
CAGR 5y | 60.51% |
CAGR/Mean DD 5y | 11.24 |
Sharpe Ratio 12m | 1.45 |
Alpha | 38.00 |
Beta | 0.84 |
Volatility | 44.59% |
Current Volume | 354.8k |
Average Volume 20d | 326.4k |
What is the price of MRX stocks?
As of December 22, 2024, the stock is trading at USD 30.18 with a total of 354,800 shares traded.
Over the past week, the price has changed by -1.40%, over one month by +4.90%, over three months by +29.93% and over the past year by +60.51%.
As of December 22, 2024, the stock is trading at USD 30.18 with a total of 354,800 shares traded.
Over the past week, the price has changed by -1.40%, over one month by +4.90%, over three months by +29.93% and over the past year by +60.51%.
Is Marex Group Ordinary Shares a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Marex Group Ordinary Shares is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.89 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRX as of December 2024 is 31.08. This means that MRX is currently overvalued and has a potential downside of 2.98%.
Neither. Based on ValueRay Fundamental Analyses, Marex Group Ordinary Shares is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.89 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRX as of December 2024 is 31.08. This means that MRX is currently overvalued and has a potential downside of 2.98%.
Is MRX a buy, sell or hold?
Marex Group Ordinary Shares has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy MRX.
Marex Group Ordinary Shares has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy MRX.
- Strong Buy: 4
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for MRX stock price target?
According to ValueRays Forecast Model, MRX Marex Group Ordinary Shares will be worth about 35.7 in December 2025. The stock is currently trading at 30.18. This means that the stock has a potential upside of +18.32%.
According to ValueRays Forecast Model, MRX Marex Group Ordinary Shares will be worth about 35.7 in December 2025. The stock is currently trading at 30.18. This means that the stock has a potential upside of +18.32%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 29.5 | -2.3% |
Analysts Target Price | 29.5 | -2.3% |
ValueRay Target Price | 35.7 | 18.3% |